Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last $2.85 USD
Change Today -0.09 / -3.06%
Volume 474.7K
TRXC On Other Exchanges
Symbol
Exchange
NYSE Amex
As of 4:15 PM 07/7/15 All times are local (Market data is delayed by at least 15 minutes).

transenterix inc (TRXC) Snapshot

Open
$2.92
Previous Close
$2.94
Day High
$2.93
Day Low
$2.73
52 Week High
07/7/14 - $5.15
52 Week Low
12/15/14 - $1.40
Market Cap
231.3M
Average Volume 10 Days
897.7K
EPS TTM
$-0.51
Shares Outstanding
81.1M
EX-Date
--
P/E TM
--
Dividend
--
Dividend Yield
--
Current Stock Chart for TRANSENTERIX INC (TRXC)

Related News

No related news articles were found.

transenterix inc (TRXC) Related Businessweek News

No Related Businessweek News Found

transenterix inc (TRXC) Details

TransEnterix, Inc., a medical device company, focuses on the development and commercialization of a robotic assisted surgical system in the United States and internationally. The company develops SurgiBot System, a single-incision, patient-side robotic-assisted surgery system. The SurgiBot System comprises of SurgiBot Base, a reusable robotic base that provides the platform of the system; the EndoDrive, a single port, surgical access device for abdominal surgery; and the Positioning Arm, a reusable arm that supports and repositions the SurgiBot Base at the operating table. The company also develops and manufactures flexible and rigid laparoscopic surgical instruments that are used in abdominal surgery, such as scissors, graspers, clip appliers, flexible energy device, and suction and irrigation instruments. TransEnterix, Inc. is headquartered in Morrisville, North Carolina.

98 Employees
Last Reported Date: 02/20/15

transenterix inc (TRXC) Top Compensated Officers

Chief Executive Officer, President and Direct...
Total Annual Compensation: $400.0K
Chief Financial Officer, Principal Accounting...
Total Annual Compensation: $282.8K
Compensation as of Fiscal Year 2014.

transenterix inc (TRXC) Key Developments

TransEnterix Submits 510(k) Application to FDA for SurgiBot System

TransEnterix, Inc. announced the submission of its 510(k) application with the U.S. Food and Drug Administration (FDA) for clearance of the company’s SurgiBot™ System. The SurgiBot System is the first patient-side, robotically enhanced laparoscopy platform. The company goal is to usher in the next wave of minimally invasive surgery by delivering excellent instrument dexterity and precision, surgeon comfort, and minimize patient incisions. The system is also designed to be mobile, minimize reliance on additional staff, and be cost-effective for many types of surgical facilities. The surgical approach and motions used with the SurgiBot are intended to mimic established laparoscopic surgical techniques. The system utilizes flexible instruments through articulating channels controlled directly by the surgeon, with robotic assistance, from within the sterile field. The flexible nature of the system allows multiple instruments to be introduced and deployed through a single incision.

TransEnterix, Inc. Reports Unaudited Consolidated Earnings Results for the First Quarter Ended March 31, 2015; Anticipates to Submit 510(K) for the SurgiBot System in June 2015

TransEnterix, Inc. reported unaudited consolidated earnings results for the first quarter ended March 31, 2015. Operating loss was $9,839,000 compared to $7,158,000 a year ago. Net loss was $10,120,000 compared to $7,479,000 a year ago. Net loss per share - basic and diluted was $0.16 compared to $0.15 a year ago. Net cash and cash equivalents used in operating activities was $8,214,000 compared to $6,459,000 a year ago. Purchase of property and equipment was $155,000 compared to $187,000 a year ago. The company announced that it is now anticipates being in a position to make 510(k) submission for the SurgiBot system in June 2015.

TransEnterix, Inc. to Report Q1, 2015 Results on May 06, 2015

TransEnterix, Inc. announced that they will report Q1, 2015 results at 8:30 AM, US Eastern Standard Time on May 06, 2015

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
TRXC:US $2.85 USD -0.09

TRXC Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Intuitive Surgical Inc $481.47 USD +3.37
Johnson & Johnson $98.92 USD +0.72
Medtronic PLC $73.46 USD -0.07
View Industry Companies
 

Industry Analysis

TRXC

Industry Average

Valuation TRXC Industry Range
Price/Earnings NM Not Meaningful
Price/Sales 608.5x
Price/Book 1.7x
Price/Cash Flow NM Not Meaningful
TEV/Sales 650.3x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact TRANSENTERIX INC, please visit www.transenterix.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.